The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...

The Company believes the study's findings support the clinical equivalence of HeartBeam's synthesized 12-lead ECG where the leads are similar to standard 12-lead ECGs for rhythm and arrhythmia ...

(Photo: Business Wire) AK+ Guard is designed to work with a wide range of FDA-cleared consumer and clinical wearables that currently capture Lead I ECG data (e.g., smartwatches), enabling ...